[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:igg":3},{"name":4,"total":5,"recruiting":5,"trials":6},"IgG",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07201558","Study Evaluating Safety, Tolerability, PK\u002FPD of Surovatamig in Adult RA or SLE Participants",[11],"Phase 1","RECRUITING","2026-08-26T02:17:36.611194Z","2026-07-05T05:32:16.666464Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06033196","Tocilizumab in Lung Transplantation",[19],"Phase 2","2026-08-26T02:18:21.216897Z","2026-05-05T02:43:26.980832Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":27,"content_modified":28},"NCT07582432","A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma",[26],"Phase 3","2026-08-26T02:15:47.754948Z","2026-05-13T02:55:06.792854Z"]